#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Autoinflammation with infantile enterocolitis Trigeminal neuralgia Adenomatous polyposis coli Osteosarcoma metastatic Exudative retinopathy Chorioretinitis Epilepsy Primary adrenal insufficiency Activated PI3 kinase delta syndrome Myxoid liposarcoma Hypotransferrinaemia Shprintzen-Goldberg syndrome Biliary neoplasm Pulmonary sarcoidosis Angiosarcoma metastatic More trials…
Learn about Rare Diseases

Rett syndrome – Life with Disease SAPHO syndrome – Trials in Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Treatment Pleural mesothelioma malignant – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Short-bowel syndrome – Treatment Atypical haemolytic uraemic syndrome – Life with Disease Hereditary motor and sensory neuropathy – Basic Information Myelodysplastic syndrome – Treatment Short-bowel syndrome – Diagnostics More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

ANUMIGILIMAB FRUQUINTINIB Mr0005 Budigalimab Enalapril Elritercept 4-Hydroxy-N-Desmethyltamoxifen Mirabegron TRIGLYCERIDES MEDIUM CHAIN HYDROGEN PEROXIDE TEV-53408 Panobinostat IPN01195 Atidarsagene Autotemcel Meropenem Anhydrous Solrikitug Camphor Blu-451 Ptc518 Nicotine More therapies…

Learn about Your Condition

Heparin resistance Agitation postoperative Mucopolysaccharidosis III Endometrial cancer recurrent Fracture infection Weaning failure HER2 positive breast cancer Anal cancer stage II Bronchopulmonary aspergillosis Ovarian epithelial cancer T-cell lymphoma Cold type haemolytic anaemia Aplastic anaemia Open angle glaucoma Cataract More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Borderline personality disorder

Study on Oxytocin and Self-Compassion Training for Patients with Borderline Personality Disorder

Recruiting

3 1 1
Investigated Diseases:
- Borderline personality disorder
Investigated Drugs:
- Oxytocin
A study to evaluate the effectiveness and safety of AP707 in patients with borderline personality disorder.

Not yet recruiting

2 1
Investigated Diseases:
- Borderline personality disorder
Investigated Drugs:
- Adezunap
Ketamine Infusion Study for Symptom Improvement in Patients with Severe Borderline Personality Disorder

Not yet recruiting

2 1 1 1
Investigated Diseases:
- Borderline personality disorder
Investigated Drugs:
- Ketamine Hydrochloride

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Borderline personality disorder

Study on Oxytocin and Self-Compassion Training for Patients with Borderline Personality Disorder

A study to evaluate the effectiveness and safety of AP707 in patients with borderline personality disorder.

Ketamine Infusion Study for Symptom Improvement in Patients with Severe Borderline Personality Disorder

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies